1. Home
  2. SHIM vs ADVM Comparison

SHIM vs ADVM Comparison

Compare SHIM & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$2.69

Market Cap

97.5M

Sector

N/A

ML Signal

HOLD

Logo Adverum Biotechnologies Inc.

ADVM

Adverum Biotechnologies Inc.

HOLD

Current Price

$4.36

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
ADVM
Founded
1990
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.5M
94.6M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
SHIM
ADVM
Price
$2.69
$4.36
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.60
AVG Volume (30 Days)
34.9K
497.5K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$495,984,000.00
N/A
Revenue This Year
$6.91
$1,192.00
Revenue Next Year
$13.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$1.78
52 Week High
$3.50
$6.12

Technical Indicators

Market Signals
Indicator
SHIM
ADVM
Relative Strength Index (RSI) 55.87 58.20
Support Level $2.55 $4.15
Resistance Level $2.73 $4.23
Average True Range (ATR) 0.21 0.09
MACD 0.02 0.02
Stochastic Oscillator 76.82 95.22

Price Performance

Historical Comparison
SHIM
ADVM

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: